Showing results (541-550 of 610) with videos related to

Sort By:
Pageof 61
Circulation|January 11, 2000
Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in ratsW Budts, P Pokreisz, Z Nong, et al.
The Journal of Clinical Investigation|December 1, 1993
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterizationP Carmeliet, L Kieckens, L Schoonjans, et al.
The Journal of Clinical Investigation|December 1, 1993
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysisP Carmeliet, J M Stassen, L Schoonjans, et al.
Science (New York, N.Y.)|November 2, 1984
Elemental anomalies at the cretaceous-tertiary boundary, woodside creek, new zealandR R Brooks, R D Reeves, X H Yang, et al.
Nature Genetics|December 17, 1997
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationP Carmeliet, L Moons, R Lijnen, et al.
Thrombosis and Haemostasis|February 3, 1987
Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosisI Juhan-Vague, J Valadier, M C Alessi, et al.
Journal of the American College of Cardiology|September 1, 1989
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PAA E Arnold, R W Brower, D Collen, et al.
The Journal of Biological Chemistry|October 25, 1988
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)P J Declerck, M De Mol, M C Alessi, et al.
American Heart Journal|April 27, 2000
Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS)P W Armstrong, J R Burton, D Palisaitis, et al.
Circulation|March 1, 1991
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparationT Yasuda, H K Gold, R C Leinbach, et al.
Pageof 61